21-43065417-G-C
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 1P and 4B. PP2BP4_Strong
The NM_000071.3(CBS):c.636C>G(p.Asn212Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. N212N) has been classified as Benign.
Frequency
Consequence
NM_000071.3 missense
Scores
Clinical Significance
Conservation
Publications
- classic homocystinuriaInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, PanelApp Australia, ClinGen, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CBS | NM_000071.3 | c.636C>G | p.Asn212Lys | missense_variant | Exon 7 of 17 | ENST00000398165.8 | NP_000062.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CBS | ENST00000398165.8 | c.636C>G | p.Asn212Lys | missense_variant | Exon 7 of 17 | 1 | NM_000071.3 | ENSP00000381231.4 |
Frequencies
GnomAD3 genomes Cov.: 5
GnomAD2 exomes AF: 0.000116 AC: 29AN: 250098 AF XY: 0.000185 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000187 AC: 84AN: 448080Hom.: 19 Cov.: 4 AF XY: 0.000321 AC XY: 77AN XY: 239924 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 5
ClinVar
Submissions by phenotype
Classic homocystinuria Uncertain:1
not provided Uncertain:1
p.Asn212Lys (AAC>AAG): c.636 C>G in exon 7 of the CBS gene (NM_000071.2). A variant of unknown significance has been identified in the CBS gene. To our knowledge, the N212K variant has not been published as a disease-causing mutation nor as a benign polymorphism to our knowledge. The N212K variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The N212K variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is mostly conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. A missense mutation in nearby residue (S217F) has been reported in association with homocystinuria, supporting the functional importance of this region of the protein. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. This variant was found in TAAD
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at